CenterStar Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-3,300
Closed -$424K – 292
2026
Q2
$424K Buy
3,300
+600
+22% +$70.2K 0.07% 157
2026
Q1
$325K Sell
2,700
-18,800
-87% -$2.17M 0.04% 385
2025
Q4
$2.26M Buy
+21,500
New +$2.02M 0.64% 36
2022
Q2
– Hold
0
– -$1.39M – 553
2022
Q1
– Hold
0
– – – 180
2021
Q4
– Hold
0
– -$85K – 776
2021
Q3
– Hold
0
– – – 602
2020
Q4
– Hold
0
– -$382K – 855
2020
Q3
– Hold
0
– – – 336
2020
Q2
– Hold
0
– – – 43
2020
Q1
– Hold
0
– – – 217
2019
Q4
– Hold
0
– – – 182
2019
Q2
– Hold
0
– -$25K – 398
2019
Q1
– Hold
0
– – – 198
2018
Q4
– Hold
0
– – – 224
2018
Q3
– Hold
0
– – – 245
2018
Q2
– Hold
0
– – – 586

Other funds holding MRK

CenterStar Asset Management's MRK Position: Q3 2023 in Review

CenterStar Asset Management sold out of Merck (MRK) in Q3 2023, closing a stake of 9,874 shares — an estimated $1.14M sold.

CenterStar Asset Management first reported a position in MRK in Q2 2023 and held it in 1 quarter. The position peaked at $1.14M in Q2 2023. 3,215 funds tracked by Wall St. Rank hold MRK as of Q3 2023.

  • CenterStar Asset Management reported no remaining Merck position as of Q3 2023 after selling out during the quarter.
  • CenterStar Asset Management sold 9,874 Merck shares in Q3 2023, an estimated $1.14M.
  • CenterStar Asset Management first reported a position in Merck in Q2 2023 and held it in 1 quarter.
  • CenterStar Asset Management's Merck position peaked at $1.14M in Q2 2023.
  • 3,215 funds tracked by Wall St. Rank held Merck as of Q3 2023.

Based on CenterStar Asset Management's 13F filing for Q3 2023, filed 19 Oct 2023.